Literature DB >> 16357216

A human, ATP-independent, RISC assembly machine fueled by pre-miRNA.

Elisavet Maniataki1, Zissimos Mourelatos.   

Abstract

RNA interference (RNAi) is mediated by RNA-induced silencing complexes (RISCs), which are guided by microRNAs (miRNAs) or short interfering RNAs (siRNAs) to cognate RNA targets. In humans, the catalytic engine of RISC is a ribonucleoprotein formed by the Argonaute2 (Ago2) protein and either miRNA (miRNP) or siRNA (siRNP). The Dicer nuclease produces mature miRNAs and siRNAs from pre-miRNAs and double-stranded RNA (dsRNA), respectively, and associates with Ago2. Here, we studied the assembly of human RISC by presenting pre-miRNA to immunopurified complexes that contain Ago2, Dicer, and TRBP. Mature miRNAs were produced in an ATP-independent manner and guided specific cleavage of cognate RNA targets in a pattern that is typical of RISC. This de novo formed RISC activity dissociated from Dicer. The asymmetry of the RISC loading process was fully recapitulated in this system, which, however, could not efficiently assemble RISC from siRNA duplexes. Our findings demonstrate that, in humans, a miRNA loading complex (miRLC) is formed by Ago2 and Dicer prior to their encounter with pre-miRNA. We suggest that the miRLC couples the processing of the pre-miRNA substrate to the unwinding of the product and that after loading of the mature miRNA to Ago2, the miRLC disassembles and the miRNP is released.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16357216      PMCID: PMC1315402          DOI: 10.1101/gad.1384005

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  67 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Characterization of the interactions between mammalian PAZ PIWI domain proteins and Dicer.

Authors:  Nasser Tahbaz; Fabrice A Kolb; Haidi Zhang; Katarzyna Jaronczyk; Witold Filipowicz; Tom C Hobman
Journal:  EMBO Rep       Date:  2004-01-16       Impact factor: 8.807

3.  Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs.

Authors:  Rui Yi; Yi Qin; Ian G Macara; Bryan R Cullen
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

4.  miRNP:mRNA association in polyribosomes in a human neuronal cell line.

Authors:  Peter T Nelson; Artemis G Hatzigeorgiou; Zissimos Mourelatos
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

5.  Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila.

Authors:  Feng Jiang; Xuecheng Ye; Xiang Liu; Lauren Fincher; Dennis McKearin; Qinghua Liu
Journal:  Genes Dev       Date:  2005-06-28       Impact factor: 11.361

6.  Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs.

Authors:  Markus T Bohnsack; Kevin Czaplinski; Dirk Gorlich
Journal:  RNA       Date:  2004-02       Impact factor: 4.942

7.  Nuclear export of microRNA precursors.

Authors:  Elsebet Lund; Stephan Güttinger; Angelo Calado; James E Dahlberg; Ulrike Kutay
Journal:  Science       Date:  2003-11-20       Impact factor: 47.728

8.  RISC assembly defects in the Drosophila RNAi mutant armitage.

Authors:  Yukihide Tomari; Tingting Du; Benjamin Haley; Dianne S Schwarz; Ryan Bennett; Heather A Cook; Birgit S Koppetsch; William E Theurkauf; Phillip D Zamore
Journal:  Cell       Date:  2004-03-19       Impact factor: 41.582

9.  Normal microRNA maturation and germ-line stem cell maintenance requires Loquacious, a double-stranded RNA-binding domain protein.

Authors:  Klaus Förstemann; Yukihide Tomari; Tingting Du; Vasily V Vagin; Ahmet M Denli; Diana P Bratu; Carla Klattenhoff; William E Theurkauf; Phillip D Zamore
Journal:  PLoS Biol       Date:  2005-05-24       Impact factor: 8.029

10.  Processing of pre-microRNAs by the Dicer-1-Loquacious complex in Drosophila cells.

Authors:  Kuniaki Saito; Akira Ishizuka; Haruhiko Siomi; Mikiko C Siomi
Journal:  PLoS Biol       Date:  2005-05-24       Impact factor: 8.029

View more
  178 in total

1.  miRNAs in human cancer.

Authors:  Xiaomin Zhong; George Coukos; Lin Zhang
Journal:  Methods Mol Biol       Date:  2012

2.  Dicer is dispensable for asymmetric RISC loading in mammals.

Authors:  Juan G Betancur; Yukihide Tomari
Journal:  RNA       Date:  2011-11-21       Impact factor: 4.942

3.  Precursor microRNA-programmed silencing complex assembly pathways in mammals.

Authors:  Xuhang Liu; Dong-Yan Jin; Michael T McManus; Zissimos Mourelatos
Journal:  Mol Cell       Date:  2012-04-12       Impact factor: 17.970

Review 4.  Ancestral roles of small RNAs: an Ago-centric perspective.

Authors:  Leemor Joshua-Tor; Gregory J Hannon
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-10-01       Impact factor: 10.005

Review 5.  microRNAs in heart disease: putative novel therapeutic targets?

Authors:  Gianluigi Condorelli; Michael V G Latronico; Gerald W Dorn
Journal:  Eur Heart J       Date:  2010-01-29       Impact factor: 29.983

6.  Double-stranded Let-7 mimics, potential candidates for cancer gene therapy.

Authors:  Qi-zhao Wang; Ying-hui Lv; Yu-hua Gong; Zhao-fa Li; William Xu; Yong Diao; Ruian Xu
Journal:  J Physiol Biochem       Date:  2011-11-09       Impact factor: 4.158

Review 7.  Structural and biochemical advances in mammalian RNAi.

Authors:  Robert E Collins; Xiaodong Cheng
Journal:  J Cell Biochem       Date:  2006-12-01       Impact factor: 4.429

Review 8.  Signaling-mediated regulation of MicroRNA processing.

Authors:  Jia Shen; Mien-Chie Hung
Journal:  Cancer Res       Date:  2015-02-06       Impact factor: 12.701

Review 9.  Origins and Mechanisms of miRNAs and siRNAs.

Authors:  Richard W Carthew; Erik J Sontheimer
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

10.  Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma.

Authors:  Simion Chiosea; Elena Jelezcova; Uma Chandran; Marie Acquafondata; Teresa McHale; Robert W Sobol; Rajiv Dhir
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.